Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
You can read more about this update on our Label Updates page
Double-blind placebo-controlled study with PT-141 (MC4R-selective derivative of Melanotan II) 20 mg intranasally
This is already seen in the U.S., where some retailers have reported that their 2023 second-quarter sales have been boosted by prescription weight-loss drugs
They have obesity, but it's preclinical obesity as a disease
Treatment with anti-somatostatin antibodies or co-infusion with a somatostatin receptor 2 antagonist eliminated the GLP- 1-mediated suppression of glucagon secretion [71]
US$ 23.85
US$ 23.23
US$ 28.46
US$ 22.06
US$ 26.94
.webp)
US$ 20.18
